PETER J. GRUA - 06 Mar 2025 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
06 Mar 2025
Net transactions value
+$99,470
Form type
4
Filing time
10 Mar 2025, 08:13:36 UTC
Previous filing
10 Jun 2024
Next filing
09 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Purchase $99,470 +11,040 +143% $9.01 18,749 06 Mar 2025 Direct F1, F2
holding EVH Class A Common Stock 41,919 06 Mar 2025 By the Peter J. Grua 2004 Revocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.74-9.34, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 These shares are held in a trust for the sole benefit of the reporting person. The reporting person is the sole trustee of the trust and has sole voting and dispositive power over the shares.